NEW YORK (GenomeWeb) – Macrogen and Silicon Biosystems Menarini announced today that they are partnering to co-develop CLIA-certified genomic tests for different cancers.

The companies plan to combine Silicon Biosystems' DEPArray digital-sorting technology with Macrogen's high-throughput whole-genome, whole-exome, and targeted sequencing systems to resolve cellular heterogeneity of formalin-fixed paraffin-embedded (FFPE) biopsies and fine-needle aspiration (FNA) samples.

Financial terms of the deal were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine writes that proteomics might be better poised than genomics to say when someone is falling ill.

Bloomberg profiles IndieBio, a startup incubator for the life sciences.

In an editorial, Nature calls for the end to the exploitation of foreign postdocs.

In Nucleic Acids Research this week: collection of epigenome-wide association study data, updated BloodSpot database, and more.